Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
von Planta
M
M
Department of Internal Medicine, University Hospital, Basel, Switzerland.
Chamberlain
D
D
D000638:Amiodarone / Q000627:therapeutic use; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000628:therapy; D001285:Atropine / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D016887:Cardiopulmonary Resuscitation; D003131:Combined Modality Therapy; D004554:Electric Countershock; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008274:Magnesium / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D001949:Bretylium Compounds; D001285:Atropine; D008012:Lidocaine; D008274:Magnesium; D000638:Amiodarone; C045166:bretylium; D002118:Calcium